If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: When 'Not So Bad' Is Actually Pretty Good
Closing Bell: Bristol-Myers Squibb Leads Healthcare; U.S. Stocks Slide as Defensive Names Slip
Cramer: Here's the Secret to Driving Stocks Higher in This Market
Stock Losses Accelerate in Final Hour as Defensive Names Sell Off